Participating Faculty

Supplements and Featured Publications, Breakthrough Pain in Chronic Persistent Pain Syndromes: Emerging Treatment Options and Implications , Volume 14, Issue 4 Suppl

Faculty/Authors

Barry V. Fortner, PhD

(Chair)

Senior Vice President, Scientific Affairs and Provider Services

P4 Healthcare

Lakeland, Tennessee

Adjunct Professor of Graduate Psychology

University of Memphis

Memphis, Tennessee

Amy P. Abernethy, MD

Assistant Professor of Medicine—Oncology

Attending Physician, Center for Palliative Care

Duke University School of Medicine

Durham, North Carolina

David A. Fishbain, MD, FAPA (dist.)

Professor of Psychiatry and Adjunct Professor of

Neurological Surgery and Anesthesiology

Miller School of Medicine at the University of Miami

Miami, Florida

Lynn R.Webster, MD, FACPM, FASAM

Medical Director

Lifetree Clinical Research and Pain Clinic

Salt Lake City, Utah

Jane L. Wheeler

Research Associate

Duke Cancer Care Research Program

Duke University School of Medicine

Durham, North Carolina

Faculty Disclosures

When asked to report any potential conflict(s) of interest, faculty reported the following:

Amy P. Abernethy, MD

Grant/research support:

Cephalon

Lynn R.Webster, MD, FACPM, FASAM

Grant/research support:

Advanced Bionics

CoMentis

DURECT

Elan Pharmaceuticals

Elite

Forest Laboratories

GlaxoSmithKline

Jazz Pharmaceuticals

Mallinckrodt

Medtronic

Merck & Co, Inc

NeurogesX

Predix

Purdue Pharma

Takeda Pharmaceuticals

TorreyPines Therapeutics

ZARS Pharma

Consultant for:

Advanced Bionics

Cephalon

Elan Pharmaceuticals

King Pharmaceuticals

Medtronic

Barry V. Fortner, PhD, David A. Fishbain, MD, FAPA

(dist.), and Jane L.Wheeler

have no relevant conflicts

to report.

All SciMed personnel involved in the development of content for this activity have no relevant conflicts to report.

The materials for this activity were peer reviewed by

Kenneth L. Kirsh, PhD, Assistant Professor, Pharmacy

Practice and Science, University of Kentucky.

Dr Kirsh had no relevant conflicts to report.

SciMed assesses conflicts of interest with its faculty and all individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are resolved by SciMed to ensure fair balance and scientific objectivity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Princeton, New Jersey.

Cephalon, Inc.

This supplemented was supported by